Clinical Trial for Brain Cancer Glioblastoma Immunotherapy SurVaxM

Roswell Park Spinoff Company Advances Toward New Clinical Trial for Brain Cancer Immunotherapy SurVaxM MimiVax LLC and Roswell Park to launch large clinical trial at centers in U.S. & abroad following major licensing deal MimiVax LLC secures $10 million upfront in licensing deal Large phase II studies expected

Read more